55 related articles for article (PubMed ID: 36397094)
21. Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study.
Feola T; Puliani G; Sesti F; Modica R; Centello R; Minotta R; Cannavale G; Di Meglio S; Di Vito V; Lauretta R; Appetecchia M; Colao A; Lenzi A; Isidori AM; Faggiano A; Giannetta E
J Endocrinol Invest; 2022 Apr; 45(4):849-857. PubMed ID: 35040099
[TBL] [Abstract][Full Text] [Related]
22. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of selective arterial calcium injection tests for functional pancreatic neuroendocrine tumors.
Nakano Y; Kitago M; Shinoda M; Nakatsuka S; Kurihara I; Yagi H; Abe Y; Oshima G; Hori S; Yokose T; Kitagawa Y
Sci Rep; 2021 Jan; 11(1):235. PubMed ID: 33420290
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.
Muscogiuri G; Altieri B; Albertelli M; Dotto A; Modica R; Barrea L; Fanciulli G; Feola T; Baldelli R; Ruggeri RM; Gallo M; Guarnotta V; Malandrino P; Messina E; Venneri MA; Giannetta E; Ferone D; Colao A; Faggiano A;
Endocrine; 2020 Aug; 69(2):441-450. PubMed ID: 32468269
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of selective arterial calcium injection test for localization of gastrinoma.
Hayashi R; Minami I; Sasahara Y; Izumiyama H; Yoshimoto T; Kishino M; Kudo A; Tateishi U; Tanabe M; Yamada T
Endocr J; 2020 Mar; 67(3):305-315. PubMed ID: 31813923
[TBL] [Abstract][Full Text] [Related]
26. Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 Centimeters.
Faggiano A; Modica R; Lo Calzo F; Camera L; Napolitano V; Altieri B; de Cicco F; Bottiglieri F; Sesti F; Badalamenti G; Isidori AM; Colao A
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31586182
[TBL] [Abstract][Full Text] [Related]
27. Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study.
Sallinen VJ; Le Large TYS; Tieftrunk E; Galeev S; Kovalenko Z; Haugvik SP; Antila A; Franklin O; Martinez-Moneo E; Robinson SM; Panzuto F; Regenet N; Muffatti F; Partelli S; Wiese D; Ruszniewski P; Dousset B; Edwin B; Bartsch DK; Sauvanet A; Falconi M; Ceyhan GO; Gaujoux S;
HPB (Oxford); 2018 Mar; 20(3):251-259. PubMed ID: 28988702
[TBL] [Abstract][Full Text] [Related]
28. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
[TBL] [Abstract][Full Text] [Related]
30. Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms.
Partelli S; Cirocchi R; Crippa S; Cardinali L; Fendrich V; Bartsch DK; Falconi M
Br J Surg; 2017 Jan; 104(1):34-41. PubMed ID: 27706803
[TBL] [Abstract][Full Text] [Related]
31. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
Falconi M; Eriksson B; Kaltsas G; Bartsch DK; Capdevila J; Caplin M; Kos-Kudla B; Kwekkeboom D; Rindi G; Klöppel G; Reed N; Kianmanesh R; Jensen RT;
Neuroendocrinology; 2016; 103(2):153-71. PubMed ID: 26742109
[No Abstract] [Full Text] [Related]
32. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
Rosenberg AM; Friedmann P; Del Rivero J; Libutti SK; Laird AM
Surgery; 2016 Jan; 159(1):302-9. PubMed ID: 26547726
[TBL] [Abstract][Full Text] [Related]
33. Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).
Jung JG; Lee KT; Woo YS; Lee JK; Lee KH; Jang KT; Rhee JC
Medicine (Baltimore); 2015 Jul; 94(26):e983. PubMed ID: 26131843
[TBL] [Abstract][Full Text] [Related]
34. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
35. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.
Ito T; Igarashi H; Nakamura K; Sasano H; Okusaka T; Takano K; Komoto I; Tanaka M; Imamura M; Jensen RT; Takayanagi R; Shimatsu A
J Gastroenterol; 2015 Jan; 50(1):58-64. PubMed ID: 24499825
[TBL] [Abstract][Full Text] [Related]
36. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).
Hashim YM; Trinkaus KM; Linehan DC; Strasberg SS; Fields RC; Cao D; Hawkins WG
Ann Surg; 2014 Feb; 259(2):197-203. PubMed ID: 24253141
[TBL] [Abstract][Full Text] [Related]
37. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
[TBL] [Abstract][Full Text] [Related]
38. Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome.
Norton JA; Fraker DL; Alexander HR; Jensen RT
Ann Surg; 2012 Sep; 256(3):509-17. PubMed ID: 22868363
[TBL] [Abstract][Full Text] [Related]
39. Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma.
Bartsch DK; Waldmann J; Fendrich V; Boninsegna L; Lopez CL; Partelli S; Falconi M
Br J Surg; 2012 Sep; 99(9):1234-40. PubMed ID: 22864882
[TBL] [Abstract][Full Text] [Related]
40. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor.
Bettini R; Partelli S; Boninsegna L; Capelli P; Crippa S; Pederzoli P; Scarpa A; Falconi M
Surgery; 2011 Jul; 150(1):75-82. PubMed ID: 21683859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
